The National Chamber of Innovative Healthcare held talks with AstraZeneca on the possible cooperation in a number of areas, the chamber said in statement.
Today, for the Uzbek healthcare, it is important to develop and adopt clinical protocols based on evidence-based medicine. That is, those guides to action for each doctor, which will help to build the treatment of patients in Uzbekistan, taking into account international best practices. A partner such as a world-renowned AstraZeneca can help the National Chamber and the Uzbekistan healthcare in general in attracting renowned international experts, whose experience will expedite the process of developing modern Clinical Protocols for local doctors, the statement noted.
“For example, there is an opportunity to attract experts who took part in updating the Russian Clinical Protocols in Endocrinology in April. By attracting such experts to Uzbekistan, it is possible to speed up the development and adoption of truly effective modern clinical protocols and guidelines. And we are ready to support in this," said Zamira Kulmanbetova, head of the Strategic Partnership Development Department of AstraZeneca in the Eurasian cluster, during the meeting on April 22, 2021.
She emphasized that the reforms of the Uzbekistan medical sector today help to bring latest pharmaceuticals in the country, developed using high technologies. In particular, this company, which has not been present in the country for a long time, has registered a number of its latest developments in Uzbekistan over the past two years, including drugs for cancer patients.
“We are returning to Uzbekistan again largely due to the wonderful changes that are taking place in your country. In particular, thanks to the fast-track "registration by recognition". This is just a wonderful huge step that you have taken,” said Z. Kulmanbetova.
At the same time, according to her, for the full effectiveness of the changes that allow modern pharmaceuticals to come to the country, it is also necessary to change the LEM system (List of Essential Medicines). In this country it is revised once every two years, which means that new pharmaceuticals will be added to it no earlier than in a year or two. As noted at the meeting, such a system for revising the LEM has remained only in Uzbekistan. In particular, in Russia, LEM is reviewed once a year, and in addition, in some cases, there are additional revisions when it comes to the possibility of using innovative therapy.
She also pointed to the need to exchange experience in order to develop the system of compulsory health insurance, a pilot project for which was launched in Uzbekistan, partnerships in enhancing skills of health professionals and a number of other areas.
